Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Sodium Salicylate in Treating Patients With Advanced Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment
- Status
- TERMINATED
- Phase
- PHASE1
Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
- Status
- TERMINATED
- Phase
- PHASE1
Chemotherapy in Treating Patients Who Have Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer
- Status
- UNKNOWN
- Phase
- PHASE1
6-Hydroxymethylacylfulvene in Treating Patients With Refractory Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Blastic Phase Chronic Myelogenous Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Monoclonal Antibody Therapy in Treating Patients With Primary Myelodysplastic Syndrome
- Status
- WITHDRAWN
- Phase
- PHASE2
Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy in Treating Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease
- Status
- COMPLETED
- Phase
- PHASE2
Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma
- Status
- UNKNOWN
- Phase
- PHASE2
Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE2
Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3